EYE/EAR DROPS 

by

EYE/EAR DROPS 

S.no GENERIC NAME COMPOSTION REF

.

 CLAIM STRENGTH
1. Atropine Sulphate Ophthalmic Solution IP Composition:
Atropine Sulphate IP 1%, w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
2.  

Atropine sulphate ophthalmic solution IP

 Composition:
Atropine sulphate IP 0.01%&0.05% w/v
StabilisedOxychloro Complex

(As Preservative)

 0.005% v/v
Sterile Aqueous Base q.s
3. Amikacin Sulphate (1%) &(0.3%) HPMC

Ophthalmic Solution

 Composition:
Amikacin Sulphate Eq. to Amikacin IP 1%&0.3% w/v
Hydroxypropylmethyl Cellulose IP 0.025 % w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
4. Alcaftadine Ophthalmic Solution Composition:
Alcaftadine 0.25% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.005% v/v
Sterile Aqueous Base q.s
5. Amikacin Sulphate (1%)&(0.3%)

Dexamethasone & HPMC Ophthalmic Solution

 Composition:
Amikacin Sulphate Eq. to Amikacin IP 1%&0.3% w/v
Dexamethasone Sodium Phosphate IP 0.1% w/v
Hydroxypropylmethyl Cellulose IP 0.025 % w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
6. Azithromycin & Dexamethasone Eye /Ear Drops Composition:
Azithromycin IP 10.0 mg
Dexamethasone SodiumPhosphate IP 1.0 mg
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% w/v
Sterile suspension Base q.s
7. Azelastine hcl eye drop Composition:
Azelastine HCL IP 0.05% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
8. Bromfenac Composition:

 

Ophthalmic Solution Bromfenac Sodium Eq. to Bromfenac 0.09% w/v
Benzalkonium chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
9. Bimatoprost Ophthalmic Solution Composition :
Bimatoprost 0.01%&0.03% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.005% v/v
Sterile Aqueous Base q.s
10. Bimatoprost& Timolol Maleate Ophthalmic Solution Composition :
Bimatoprost 0.03%&0.01% w/v
Timolol Maleate Eq. to Timolol IP 0.5% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.005% v/v
Sterile Aqueous Base q.s
11. Brimonidine Tartrate Eye drop IP Composition :
Brimonidine Tartrate IP 0.2%&0.10% w/v
StabilisedOxychloro Complex

(As Preservative)

 0.005% v/v
Sterile Aqueous Base q.s
12. Brimonidine Tartrate Eye drop IP Composition :
Brimonidine Tartrate IP 0.15% w/v
Stabilised Oxychloro Complex

(As Preservative)

 0.005% w/v
Sterile Aqueous Base q.s
13. Brimonidine Tartrate & Timolol Maleate Ophthalmic Solution Composition :
Brimonidine Tartrate IP 0. 2% w/v
Timolol Maleate Eq. to Timolol IP 0.5% w/v
StabilisedOxychloro Complex

(As Preservative)

 0.005% w/v
Sterile Aqueous Base q.s
14. Brimonidine Tartrate & Timolol Maleate Ophthalmic Solution Composition :
Brimonidine Tartrate IP 0. 2% w/v
Timolol Maleate Eq. to Timolol IP 0.5% w/v
StabilisedOxychloro Complex

(As Preservative)

 0.005% w/v
Sterile Aqueous Base q.s
15. Brinzolamide eye Drops IP Composition :
Brinzolamide

(Sterile &Miicronized)

 IP 1.0% w/v

 

Benzalkonium Chloride (As Preservative) IP 0.02% v/v
Sterile Suspension Base q.s
16. Brinzolamide & Brimonidine Tartrate eye Drops Composition :
Brinzolamide

(Sterile &Miicronized)

 IP 1.0% w/v
Brimonidine Tartrate IP 0. 2% w/v
Benzalkonium Chloride (As Preservative) IP 0.02% v/v
Sterile Suspension Base q.s
17. Boric Acid, Zinc Sulphate & Sodium Borate Ophthalmic Solution Composition:
Boric Acid IP 2% w/v
Zinc Sulphate IP 0.1% w/v
Sodium Borate IP 0.5% w/v
Chlorbutol

(As Preservative)

 IP 0.5% w/v
Glycerin IP 2% w/v
18. Boric Acid, Borax Zinc Sulphate & Menthol Ophthalmic Solution Composition:
Boric Acid IP 2% w/v
Borax IP 0.2% w/v
Menthol IP 0.005% w/v
Zinc Sulphate IP 0.12% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base Q.S.
19. Betamethasone & Neomycin Eye/ Ear Drops Composition :
Betamethasone Sodium Phosphate IP 0.1% w/v
Neomycin Sulphate IP 0.5% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v
Sterile Aqueous Base q.s
20. Betamethasone & Chloramphenicol Eye/ Ear Drops Composition:
Betamethasone Sodium Phosphate IP 0.1% w/v
Chloramphenicol IP 0.5% w/v
Chloramphenicol IP 0.5% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v
Sterile Aqueous Base q.s
21. Betaxolol Eye drops IP Composition :
Betaxolol Hydrochloride Eq. to Betaxolol IP 0.25%&0.5%&1.0

%

 w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
22. Bepotastine Composition :

 

Ophthalmic Solution Bepotastine 1.5% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.005% v/v
Sterile Aqueous Base q.s
23. Bepotastine Besilate Eye Drops Composition :
Bepotastine Besilate Eq. to Bepotastine IP 15

10.70

 mg mg
Benzalkonium Chloride (As Preservative) IP 0.005% v/v
Sterile Aqueous Base q.s
24. Carboxymethyl Cellulose Sodium Eye drops IP

(0.5%) &(1.0%)

 Composition :
Carboxymethyl Cellulose Sodium IP 0.5%&1.0% w/v
Sodium Perborate (As Preservative) BP 0.005% w/v
Sterile Aqueous Base q.s
25. Carboxymethyl Cellulose Sodium Eye drops IP (0.5%)&(1.0%) Composition :
Carboxymethyl Cellulose

Sodium

 IP 0.5%&1.0% w/v
Stabilised Oxychloro Complex

(As Preservative)

 0.005% w/v
Sterile Aqueous Base q.s
26. Carboxymethyl Cellulose Sodium Eye drops IP

(0.5%) &(1.0%)

 Composition :
Carboxymethyl Cellulose Sodium IP 0.5%&1.0% w/v
Sterile Aqueous Base q.s
27. Carboxymethyl Cellulose Sodium Eye drops IP (0.5%) &(1.0%)

(With Glycerin)

 Composition :
Carboxymethyl Cellulose Sodium IP 0.5%&1.0% w/v
Glycerin IP 2% w/v
Sterile Aqueous Base q.s
28. Carboxymethyl Cellulose Sodium Eye drops IP (0.5%) &(1.0%)

(With Glycerin)

 Composition :
Carboxymethyl Cellulose Sodium IP 0.5%&1.0% w/v
Glycerin IP 2% w/v
Sterile Aqueous Base q.s
29. Carboxymethyl cellulose sodium with glycerin lubricant eye ointment Composition:
Carboxymethylcellulose sodium IP 0.3% w/v
Glycerin IP 1% w/v
Benzyl Alcohol (As Preservative) IP 0.1% v/v
Sterile Ointment base qs
30. Sodium CarboxymethylCellulo se & N-Acetyl- Composition
Sodium Carboxymethyl Cellulose IP 0.3% w/v

 

Carnosine Opthalmic Solution N-Acetyl-Carnosine 1% w/v
Glycerin IP 1% w/v
StabilisedOxychloro Complex

(As Preservative)

 0.005% w/v
Sterile aqueous vehicle q.s
31. Sodium Carboxymethyl Cellulose & N-Acetyl-Carnosine Opthalmic Solution Composition:
Sodium Carboxymethyl Cellulose IP 0.3% w/v
N-Acetyl-Carnosine 0.1% w/v
Glycerin IP 0.1% w/v
Boric Acid IP 0.3% w/v
StabilisedOxychloro Complex(As Preservative) 0.005% w/v
Sterile aqueous vehicle q.s
32. Chloramphenicol Eye Drops IP Composition :
Chloramphenicol IP 0.5%&1% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
33. Chloramphenicol &HPMC Ophthalmic Solution Composition :
Chloramphenicol IP 0.5% w/v
Hydroxypropylmethyl Cellulose IP 0.025% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
34. Chloramphenicol, Dexamethasone &HPMC Eye/Ear Drops Composition :
Chloramphenicol IP 1% w/v
Dexamethasone SodiumPhosphate IP 0.01% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
35. Chloramphenicol & Dexamethasone Sodium Phosphate & HPMC Ophthalmic Solution Composition :
Chloramphenicol IP 0.5% w/v
Dexamethasone Sodium Phosphate IP 0.1% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
36. Chlorpheniramine Maleate, Phenylephrine HCl & HPMC Eye/Ear drops Composition:
Chlorpheniramine Maleate IP 0.2% w/v
Phenylephrine Hydrochloride IP 0.12% w/v
Hydroxypropylmethyl Cellulose IP 0.02% w/v
Phenylmercuric Nitrate (As Preservative) IP 0.001% w/v

 

Sterile Aqueous Base q.s
37. Ciprofloxacin Eye drops IP Composition :
Ciprofloxacin Hydrochloride

Eq. to Ciprofloxacin

 IP 0.3% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
38. Ciprofloxacin & HPMC

Eye/ Ear drops

 Composition :
Ciprofloxacin Hydrochloride

Eq. to Ciprofloxacin

 IP 0.3% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
39. Ciprofloxacin & Dexamethasone Sodium Phosphate Eye/Ear drops Composition :
Ciprofloxacin HCL

Eq. to Ciprofloxacin

 IP 0. 3% w/v
Dexamethasone SodiumPhosphate

Eq.to Dexamethasone phosphate

 IP 0.1% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
40. Ciprofloxacin & Dexamethasone Sodium Phosphate & HPMC Eye/Ear drops Composition :
Ciprofloxacin Hydrochloride

Eq. to Ciprofloxacin

 IP 0. 3% w/v
Dexamethasone SodiumPhosphate IP 0.01% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
41. Cyclopentolate Eye drops IP Composition:
Cyclopentolate Hydrochloride IP 1% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
42. Cromolyn Sodium Opthalmic Solution USP Composition:
Sodium Cromoglycate USP 2 %& 4% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
43. Cyclosporine Composition :

 

Eye drops Cyclosporine IP 1.0&2.0&0.5 mg
Benzalkonium Chloride (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
44. Diclofenac Sodium Ophthalmic Solution Composition :
Diclofenac Sodium IP 0.1% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
45. Dorzolamide Eye drops IP Composition :
Dorzolamide Hydrochloride

Eq. to Dorzolamide

 IP 2.0% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
46. Dorzolamide and Timolol

Eye Drops IP

 Composition :
Dorzolamide Hcl Eq.to Dorzolamide IP 2% w/v
Timolol Maleate Eq. to Timolol IP 0.5% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
47. Dexamethasone Sodium Phosphate Eye Drops USP Composition :
Dexamethasone Sodium Phosphate IP 0.01%&0.1% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
48. Dexamethasone & Neomycin Sulphate & HPMC Eye/Ear drops Composition :
Dexamethasone Sodium Phosphate IP 0.1% w/v
Neomycin Sulphate IP 0.5% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
49. Dexamethasone Sodium Phosphate, Neomycin Sulphate, Boric Acid with Ophthalmic Solution Composition :
Dexamethasone Sodium Phosphate IP 0.1% w/v
Neomycin Sulphate IP 0.5% w/v
Boric acid IP 1.2% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
50. Composition:

 

Sodium Phosphate, Neomycin Sulphate, Boric Acid with HPMC Ophthalmic Solution Dexamethasone Sodium Phosphate IP 0.1% w/v
Neomycin Sulphate IP 0.5% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Boric Acid IP 1.2% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
51. Difluprednate Ophthalmic Suspension Composition :
Difluprednate 0.05% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile suspension Base q.s
52. Epinastine Eye drops IP Composition :
Epinastine Hydrochloride IP 0.05% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.01% v/v
Sterile Aqueous base q.s
53. Fluorometholone Eye Drops IP Composition:
Fluorometholone IP 0.1%&0.25% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Suspension Base q.s
54. Fluorometholone& Chloramphenicol Ophthalmic Suspension Composition:
Fluorometholone IP 0.1% w/v
Chloramphenicol IP 1% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Suspension Base q.s
55. Fluorometholone& Gatifloxacin Eye/Ear Drops Composition:
Fluorometholone IP 0.1% w/v
Gatifloxacin (As Anhydrous) IP 0.3% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Suspension Base q.s
56. Flurbiprofen Sodium Eye Drops IP Composition :
Flurbiprofen Sodium IP 0.03% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
57. Flurbiprofen Sodium & HPMC Ophthalmic Solution Composition :
Flurbiprofen Sodium IP 0.03% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v

 

Sterile Aqueous Base q.s
58. Flurbiprofen Sodium & Chloramphenicol Ophthalmic Solution Composition:
Flurbiprofen Sodium IP 0.03% w/v
Chloramphenicol IP 0.5% w/v
Phenylmercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
59. Fluconazole Eye /Ear Drops Composition :
Fluconazole IP 0.3% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
60. Gatifloxacin Ophthalmic Solution Composition:
Gatifloxacin (As Anhydrous) IP 0. 3%& 0.5% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
61. Gatifloxacin& HPMC Ophthalmic Solution Composition :
Gatifloxacin

(As Anhydrous)

 IP 0. 3%&0. 5% w/v
Hydroxypropylmethyl

cellulose

 IP 0.025% w/v
Benzalkonium Chloride

Solution(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
62. Gatifloxacin& Ketorolac Tromethamine Ophthalmic Solution Composition :
Gatifloxacin

Eq. to Anhydrous Gatifloxacin

 IP  

0.3%

  

w/v
Ketorolac Tromethamine IP 0.4% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
63. Gatifloxacin& Flurbiprofen Ophthalmic Solution Composition :
Gatifloxacin (As Anhydrous) IP 0.3% w/v
Flurbiprofen sodium IP 0.03% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.001% w/v
Sterile Aqueous Base q.s
64. Gatifloxacin, Flurbiprofen &HPMC Ophthalmic Solution Composition :
Gatifloxacin (As Anhydrous) IP 0.3% w/v
Flurbiprofen Sodium IP 0.03% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v

 

Sterile Aqueous Base q.s
65. Gatifloxacin& Dexamethasone Eye/Ear drops Composition:
Gatifloxacin (As Anhydrous) IP 0. 3% w/v
Dexamethasone Sodium Phosphate IP 0.1% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
66. Gatifloxacin& Prednisolone Acetate Ophthalmic Solution Composition:
Gatifloxacin (As Anhydrous) IP 0. 3% w/v
Prednisolone Acetate IP 1.0% w/v
Benzalkonium Chloride Solution(As preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
67. Gatifloxacin& Betamethasone Sodium Phosphate & HPMC Ophthalmic Solution Composition :
Gatifloxacin

(As Anhydrous)

 IP 0. 3% w/v
Betamethasone Sodium

Phosphate

 IP 0.1% w/v
Hydroxypropylmethyl

cellulose

 IP 0.025% w/v
Benzalkonium Chloride

Solution(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
68. Gentamicin Sulphate Eye drops IP Composition :
Gentamicin Sulphate Eq. to Gentamicin IP 0.3% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
69. Gentamicin Sulphate & HPMC Eye/Ear drops Composition :
Gentamicin Sulphate Eq. to Gentamicin IP 0.3% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
70 Gentamicin & Betamethasone Eye/Ear Drops Composition :
Gentamicin Sulphate Eq. to Gentamicin IP 0.3% w/v
Betamethasone Sodium Phosphate IP 0.1% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
71. Gentamicin & Composition :

 

Betamethasone Ophthalmic Solution Gentamicin Sulphate Eq. to Gentamicin IP 0.3% w/v
Betamethasone SodiumPhosphate Eq. toBetamethasone IP  

0.01%

  

w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
72. Gentamicin, Dexamethasone& Boric Acid Ophthalmic Solutio Composition:
Gentamicin Sulphate Eq. to Gentamicin IP 0.3% w/v
Dexamethasone Sodium Phosphate IP 0.01% w/v
Boric Acid IP 1.5% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
73. Gentamicin,& Dexamethasone Ophthalmic Solution Composition:
Gentamicin Sulphate Eq. to Gentamicin IP 0.3% w/v
Dexamethasone Sodium

Phosphate

 IP 0.1% w/v
Benzalkonium Chloride

Solution(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s v/v
74. Gentamicin , Dexamethasone & HPMC Eye/Ear drops Composition :
Gentamicin Sulphate Eq. to Gentamicin IP 0.3% w/v
Dexamethasone Sodium Phosphate IP 0.01% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
75. Glycerin & CMC Ophthalmic Solution Composition:
Glycerin IP 1.0 % w/v
CMC IP 0.3% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.01% v/v
Sterile Aqueous Base q.s
76. Homatropine Hydrobromide Eye Drops IP (1%)&(2%) Composition :
Homatropine Hydrobromide IP 1%&2% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
77. Hydroxypropyl Composition:

 

methyl Cellulose Ophthalmic Solution USP Hydroxypropylmethyl Cellulose IP 0.3% w/v
StabilisedOxychloro Complex

(As Preservative)

 0.005% w/v
Sterile Aqueous Base q.s
78. Hydroxypropyl methyl Cellulose Ophthalmic Solution USP&

Hypromellose (HPMC),

 Composition:
Hydroxypropylmethyl Cellulose IP 0.3% w/v
Sodium Perborate (As Preservative) BP 0.005% w/v
Sterile Aqueous Base q.s
79. Hydroxypropyl methyl Cellulose Ophthalmic Solution USP Composition:
Hydroxypropylmethyl Cellulose IP 0.7% w/v
Sodium Perborate (As Preservative) BP 0.005% w/v
Sterile Aqueous Base q.s
80. Hydroxypropyl methyl Cellulose , Glycerin & Dextran 70 Ophthalmic Solution Composition:
Hydroxypropylmethyl

Cellulose

 IP 0.3 % w/v
Glycerin IP 0.2% w/v
Dextran 70 USP 0.1% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.01% v/v
81. HPMC, Borax, Boric Acid, Sodium chloride, & Potassium chloride

Ophthalmic Solution

 Composition:
Hydroxypropylmethyl Cellulose IP 2% w/v
Borax IP 0.19% w/v
Boric Acid IP 0.19% w/v
Sodium chloride IP 0.45% w/v
Potassium chloride IP 0.37% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
82. HPMC, Borax, Boric Acid, Sodium chloride, & Potassium chloride

Ophthalmic Solution (Hydroxypropyl methyl Cellulose Ophthalmic Solution)

 Composition:
Hydroxypropylmethyl Cellulose IP 0.7% w/v
Borax IP 0.19% w/v
Boric Acid IP 0.19% w/v
Sodium chloride IP 0.45% w/v
Potassium chloride IP 0.37% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
83. Itraconazole Ophthalmic Composition :
Itraconazole IP 1% w/v

 

Suspension Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Suspension Base q.s
84. Ketorolac Tromethamine ophthalmic Solution Composition :
Ketorolac Tromethamine IP 0.4%&0.5% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
85. Ketorolac Tromethamine &HPMC Ophthalmic Solution Composition :
Ketorolac Tromethamine IP 0.5%&0.4% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
86. Ketorolac Tromethamine & Dexamethasone Ophthalmic Solution Composition :
Ketorolac Tromethamine IP 0.5% w/v
Dexamethasone Sodium Phosphate

Eq.to Dexamethasone phosphate

 IP 0.01% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
87. Ketorolac Tromethamine, Dexamethasone Sodium Phosphate & HPMC Ophthalmic Solution Composition :
Ketorolac Tromethamine IP 0.5% w/v
Dexamethasone Sodium Phosphate IP 0.01% w/v
Hydroxypropylmethylcellul ose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
88. Ketorolac Tromethamine &Olopatadine Ophthalmic Solution Composition :
Ketorolac Tromethamine IP 0.4% w/v
Olopatadine Hcl eq. to Olopatadine IP 0.1% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.05% v/v
Sterile Aqueous Base q.s
89. Levofloxacin Ophthalmic Solution Composition:
Levofloxacin Hemihydrate eq.to Levofloxacin IP 0.5%&1.5% w/v

 

(0.5%)&(1.5%) Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
90. Levofloxacin (0.5%) & HPMC

Ophthalmic Solution

 Composition:
Levofloxacin Hemihydrate eq.to Levofloxacin IP 0.5% w/v
Hydroxypropylmethylcellul ose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
91. Loteprednol Etabonate Ophthalmic Suspension (0.2%)&(0.5%) Composition :
Loteprednol Etabonate 0.2%&0.5% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.01% v/v
Sterile Suspension Base q.s
92. Loteprednol Etabonate & Tobramycin Ophthalmic Suspension Composition:
Loteprednol Etabonate 0.5% w/v
Tobramycin Sulphate Eq.to Tobramycin IP 0.3% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.01% v/v
Sterile Suspension Base q.s
93. Latanoprost Ophthalmic Solution USP Each ml Contain:
Latanoprost USP 50 mcg
Benzalkonium Chloride

Solution(As Preservative)

 IP 0.01% v/v
Sterile Aqueous Base q.s
94. Latanoprost & Timolol Maleate Ophthalmic Solution USP Each ml Contain:
Latanoprost USP 0.005% w/v
Timolol Maleate

Eq. to Timolol

 IP 0.5% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.01% v/v
Sterile Aqueous Base q.s
95. Lomefloxacin eye drop Composition :
Lomefloxacin HCl 0.3% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.01% v/v
Sterile Aqueous Base q.s
96. Moxifloxacin Eye drop IP Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Sterile Aqueous Base q.s
97. Moxifloxacin Eye drops IP Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v

 

Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
98. Moxifloxacin & HPMC Ophthalmic Solution Composition :
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Hydroxypropylmethylcellul ose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
99. Moxifloxacin &Ketorolac Ophthalmic Solution Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Ketorolac Tromethamine IP 0.5%& 0.4% w/v
Sterile Aqueous Base q.s
100. Moxifloxacin, Ketorolac &HPMC Ophthalmic Solution Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Ketorolac Tromethamine IP 0. 4%&0. 5% w/v
Hydroxypropylmethylcellul ose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
101. Moxifloxacin, Prednisolone Acetate Ophthalmic Suspension Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Prednisolone Acetate IP 1.0% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Suspension Base q.s
102. Moxifloxacin, Prednisolone &HPMC Ophthalmic Suspension Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Prednisolone Acetate IP 1.0% w/v
Hydroxypropylmethylcellul ose IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Suspension Base q.s
103. Moxifloxacin, Dexamethasone ophthalmic Solution Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v

 

Dexamethasone Sodium Phosphate IP 0.1% w/v
Sterile Aqueous Base q.s
104. Moxifloxacin, Dexamethasone ophthalmic Solution Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Dexamethasone Sodium Phosphate IP 0.1% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
105. Moxifloxacin, Dexamethasone Eye / Ear dro Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Dexamethasone Sodium Phosphate IP 0.1% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
106. Moxifloxacin, Dexamethasone& HPMC Ophthalmic Solution Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Dexamethasone Sodium Phosphate IP 0. 1% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
107. Moxifloxacin, Betamethasone Eye / Ear drops Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Betamethasone sodium Phosphate IP 0. 1% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
108. Moxifloxacin, Betamethasone& HPMC Ophthalmic Solution Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Betamethasone sodium Phosphate IP 0. 1% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
109. Moxifloxacin& Composition :

 

Difluprednate Ophthalmic Solution Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Difluprednate 0.05% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.01% v/v
Sterile Aqueous Base q.s
110. Moxifloxacin &Bromfenac Ophthalmic Solution Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Bromfenac Sodium

Eq. toBromfenac

 0.09% w/v
Benzalkonium chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
111. Moxifloxacin HCL & Loteprednol Etabonate Ophthalmic Suspension Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0.5% w/v
Loteprednol Etabonate 0.5% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.01% w/v
Sterile Aqueous Vehicle q.s
112. Moxifloxacin & Tobramycin Ophthalmic Solution Composition:
Moxifloxacin Hydrochloride

eq. to Moxifloxacin

 IP 0. 5% w/v
Tobramycin Sulphate Eq.to Tobramycin IP 0.3% w/v
Benzalkonium chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
113. Natamycin Ophthalmic Suspension IP Composition :
Natamycin IP 5%&2% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
114. Nepafenac Ophthalmic Suspension IP Composition:
Nepafenac IP 0.1% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Suspension Base q.s.
115. Norfloxacin Eye Drops IP Composition :
Norfloxacin IP 0.3% w/v
Benzalkonium Chloride

Solution (As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
116. Norfloxacin & HPMC Ophthalmic Solution Composition :
Norfloxacin IP 0.3% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v

 

Sterile Aqueous Base q.s
117. Norfloxacin, Betamethasone &HPMC Eye /Ear drops Composition:
Norfloxacin IP 0.3% w/v
Betamethasone Sodium Phosphate IP 0.01% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
118. Norfloxacin & Dexamethasone Sodium Phosphate & HPMC ophthalmic Solution Composition :
Norfloxacin IP 0.3% w/v
Dexamethasone Sodium Phosphate IP 0.01% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
119. Naphazoline , Chlorpheniramine Maleate, Zinc Sulphate, Menthol & Camphor Eye drops Composition:
Naphazoline Hydrochloride USP 0.056 % w/v
Chlorpheniramine Maleate IP 0.01% w/v
Zinc Sulphate IP 0.12% w/v
Menthol IP 0.0025% w/v
Camphor USP 0.0025% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
120. Naphazoline Hydrochloride, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Eye drops Composition:
Naphazoline Hydrochloride USP 0.056 % w/v
Chlorpheniramine Maleate IP 0.2% w/v
Phenylephrine Hydrochloride IP 0.12% w/v
Methyl Para Hydroxy Benzoate(As Preservative) IP 0.1% w/v
Sterile Aqueous Base q.s
121. Naphazoline, HPMC Zinc Sulphate, Boric Acid, Sodium Chloride, Ophthalmic Solution Composition:
Naphazoline Hydrochloride USP 0.056 % w/v
Zinc Sulphate IP 0.12% w/v
Boric Acid IP 1.25% w/v
Hydroxypropyl methylcellulose IP 0.025% w/v
Sodium Chloride IP 0.05% w/v
Chlorbutol(As Preservative) IP 0.35% w/v
122. Naphazoline Hydrochloride & HPMC Ophthalmic Solution Composition :
Naphazoline Hydrochloride USP 0.056 % w/v
Hydroxypropylmethyl cellulose IP 0.006 % w/v
Sterile Aqueous Base q.s.

 

123. Ofloxacin Ophthalmic Solution IP Composition :
Ofloxacin IP 0.3% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
124. Ofloxacin with HPMC Eye/Ear drops Composition :
Ofloxacin IP 0.3% w/v
Hydroxypropylmethyl Cellulose IP 0.025% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
125. Ofloxacin & Dexamethasone Eye/Ear drops Composition:
Ofloxacin IP 0.3% w/v
Dexamethasone Sodium Phosphate

eq.to Dexamethasone Phosphate

 IP  

 

0.1%

  

 

w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
126.

.

 Ofloxacin & Dexamethasone with HPMC

Eye/Ear drops

 Composition:
Ofloxacin IP 0.3% w/v
Dexamethasone SodiumPhosphate IP 0.1% w/v
Hydroxypropylmethyl Cellulose IP 0.025% w/v
Benzalkonium Chloride

Solution(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
127. Ofloxacin with Betamethasone ophthalmic Solution Composition:
Ofloxacin IP 0.3% w/v
Betamethasone Sodium

Phosphate

 IP 0.1% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
128. Ofloxacin, Betamethasone with HPMC Eye/Ear drops Composition:
Ofloxacin IP 0.3% w/v
Betamethasone Sodium Phosphate IP 0.1% w/v
Hydroxypropylmethyl Cellulose IP 0.025% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
129. Ofloxacin & Ketorolac Tromethamine Composition:
Ofloxacin IP 0.3% w/v
Ketorolac Tromethamine IP 0.5% w/v

 

Ophthalmic Solution Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
130. Ofloxacin, Ketorolac Tromethamine & HPMC Ophthalmic Solution Composition :
Ofloxacin IP 0.3% w/v
Ketorolac Tromethamine IP 0.5% w/v
HydroxypropylmethylCellu lose IP 0.025% w/v
Benzalkonium Chloride

Solution (As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
131. Ofloxacin &Prednisolone Ophthalmic Suspension Composition:
Ofloxacin IP 0.3 % w/v
Prednisolone Acetate IP 1.0% w/v
Benzalkonium Chloride Solution IP 0.02 % v/v
Sterile suspension Base q.s.
132. Ofloxacin, Prednisolone & HPMC Ophthalmic Suspension Composition:
Ofloxacin IP 0.3 % w/v
Prednisolone Acetate IP 1.0% w/v
Hydroxypropylmethyl Cellulose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02 % v/v
Sterile suspension Base q.s.
133. Olopatadine Ophthalmic Solution IP Composition:
OlopatadineHydrochloride Eq. to Olopatadine IP 0.1%&0.2% w/v
Benzalkonium Chloride solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
134. Olopatadine with HPMC

Ophthalmic Solution

 Composition:
OlopatadineHydrochloride Eq. to Olopatadine IP 0.1%&0.2% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
135 Phenylephrine Hydrochloride Eye Dro Composition:
Phenylephrine Hydrochloride IP 5%&10%&2.5% w/v
Benzalkonium Chloride (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
136. Pilocarpine Hydrochloride Ophthalmic Solution USP Composition :
Pilocarpine Hydrochloride USP 2%&4% w/v
Benzalkonium Chloride solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
137. Pilocarpine Nitrate Composition :

 

Eye Drops IP (1%) Pilocarpine Nitrate IP 1%& 2% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
138. Pilocarpine Nitrate & HPMC Eye Drops Composition :
Pilocarpine Nitrate IP 1%&2% w/v
Hydroxypropylmethyl Cellulose IP 0.025 % w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
139. Proparacaine Ophthalmic SolutionUSP Composition:
Proparacaine Hydrochloride USP 0.5 % w/v
Chlorbutol(As Preservative) IP 0. 5% w/v
Sterile Aqueous Base q.s
140. Prednisolone Acetate Ophthalmic Suspension USP Composition:
Prednisolone Acetate IP 1.0% w/v
Benzalkonium Chloride Solution IP 0.02% v/v
Sterile Aqueous Base q.s.
141. Prednisolone Acetate & HPMC Ophthalmic Solution Composition
Prednisolone Acetate IP 1.0% w/v
Hydroxypropyl methyl

cellulose

 IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Suspension Base q.s
142. Povidone Iodine Ophthalmic Solution Composition:
Povidone Iodine (Available Iodine 0.5%) IP 5% w/v
Benzalkonium Chloride Solution

As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
143 Polymyxin B-Sulphate &Chloramphenicol Ophthalmic Solution Each ml contain :
Polymyxin B- Sulphate BP 5000 IU
Chloramphenicol IP 10 mg
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v
Sterile Aqueous Base q.s
144. Polymyxin B-Sulphate, Chloramphenicol & HPMC Ophthalmic Solution Each ml Contains:
Polymyxin B- Sulphate BP 5000 IU
Chloramphenicol IP 10 mg
Hydroxypropylmethyl cellulose IP 0.025% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v

 

Sterile Aqueous Base q.s.
145. Polymyxin B-Sulphate, Chloramphenicol & Dexamethasone Sodium Phosphate Ophthalmic Solution Each ml contains:
Polymyxin B- Sulphate BP 5000 IU
Chloramphenicol IP 10 Mg
Dexamethasone SodiumPhosphate Eq.to Dexamethsone phosphate IP  

0.1%

  

w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v
Sterile Aqueous Base q.s
146. Polymyxin B-Sulphate, Chloramphenicol & Dexamethasone Sodium Phosphate & HPMC Ophthalmic Solution Each ml contains:
Polymyxin B- Sulphate BP 5000 IU
Chloramphenicol IP 10 mg
Dexamethasone Sodium Phosphate IP 0.1% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v
Sterile Aqueous Base q.s
147. Polymyxin B-Sulphate, Chloramphenicol & Betamethasone Eye/Ear drops Each ml contains:
Polymyxin B- Sulphate BP 5000 IU
Chloramphenicol IP 10 Mg
Betamethasone SodiumPhosphate IP 0.1% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v
Sterile Aqueous Base q.s
148. Polymyxin B-Sulphate, Chloramphenicol & Betamethasone Sodium Phosphate & HPMC Ophthalmic Solution Each ml Contains:
Polymyxin B- Sulphate BP 5000 IU
Chloramphenicol IP 10 mg
Betamethasone Sodium Phosphate IP 0.1% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Phenyl Mercuric Nitrate

(As Preservative)

 IP 0.002% w/v
Sterile Aqueous Base q.s
149. Polyethylene Glycol & Propylene Glycol Ophthalmic Solution Composition:
Polyethylene Glycol 400 IP 0.4% w/v
Propylene Glycol IP 0.3% w/v
Polyquad (Preservative) 0.001% w/v
Sterile Aqueous Base q.s
150. Polyethylene Glycol & Propylene Glycol Ophthalmic Solution Composition:
Polyethylene Glycol 400 IP 0.4% w/v
Propylene Glycol IP 0.3% w/v
Stabilised Oxychloro Complex (As Preservative) IP 0.005% v/v

 

Sterile Aqueous Base q.s
151. Potassium Iodide, Calcium Chloride & Sodium Chloride Ophthalmic Solution Composition:
Potassium Iodide IP 3.3% w/v
Calcium Chloride (As Anhydrous) IP 1% w/v
Sodium Chloride IP 0.83% w/v
Methyl Paraben (As Preservative) IP 0.023% w/v
Propyl Paraben

(As Preservative)

 IP 0.011% w/v
Sterile Aqueous Base q.s
152. Polyvinyl Alcohol & Povidone Ophthalmic Solution Composition:
Polyvinyl Alcohol IP 1.4% w/v
Povidone IP 0.6% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
153. Sodium Chloride Ophthalmic Solution USP Composition :
Sodium Chloride IP 0.9%&5% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v
Sterile Aqueous Base q.s
154. Sodium Iodide & Mono basic Calcium Phosphate Eye /Ear drops Composition:
Sodium Iodide IP 1% w/v
Mono basic Calcium Phosphate IP 0.5% w/v
Chlorocresol

(As Preservative)

 IP 0.05% w/v
Sterile Aqueous Base q.s
155. Sodium Carboxymethyl Cellulose &

N-Acetyl-Carnosine Opthalmic Solution

 Each ml contains:
Carboxymethyl Cellulose Sodium IP 3 mg
N-Acetyl-Carnosine 10 mg
Glycerin IP 10 mg
Boric Acid IP 3 mg
Benzyl Alcohol (As Preservative) IP 0.1% v/v
Sterile aqueous vehicle q.s
156. Sodium Hyaluronate Eye Drops

(0.1%)

 Composition :
Sodium Hyaluronate IP 0.1% w/v
Stabilised Oxychloro Complex (As Preservative) IP 0.005% v/v
Sterile Aqueous Base q.s
157. Sodium Hyaluronate Eye Drops

(0.1%)

 Composition :
Sodium Hyaluronate IP 0.1% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
158. Sodium Hyaluronate Composition :

 

Eye Drops (0.15%) Sodium Hyaluronate IP 0.15%&0.18% w/v
Sterile Aqueous Base q.s
159. Soframycin (franmycetin) eye drop Composition :
Soframycin (franmycetin) 0.5% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.01% v/v
Sterile Aqueous Base q.s
160. Sulphacetamide (10%)&(20%)&(30%)

Eye Drops IP

 Composition :
Sulphacetamide Sodium IP 10%&20%&30% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v
Sterile Aqueous Base q.s
161. Sulphacetamide Sodium &HPMC Ophthalmic Solution Composition :
Sulphacetamide Sodium IP 20% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Phenyl Mercuric Nitrate (As Preservative) IP 0.002% w/v
Sterile Aqueous Base q.s
162. Sulphacetamide Sodium

With Chloramphenicol Ophthalmic Solution

 Composition :
Sulphacetamide Sodium IP 20% w/v
Chloramphenicol IP 0.5% w/v
Benzalkonium Chloride solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
163. Sulphacetamide Sodium & Chloramphenicol & HPMC Ophthalmic Solution Composition :
Sulphacetamide Sodium IP 10% w/v
Chloramphenicol IP 0.5% w/v
Hydroxypropylmethyl

cellulose

 IP 0.025% w/v
Phenyl Mercuric Nitrate

(As Preservative)

 IP 0.002% w/v
Sterile Aqueous Base q.s
164. Sparfloxacin Ophthalmic Solution Composition:
Sparfloxacin 0.3% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
165. Sparfloxacin& HPMC Ophthalmic Solution Composition :
Sparfloxacin 0.3% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
166. Timolol Maleate Eye Drops IP Composition :
Timolol Maleate Eq. toTimolol IP 0.25%&0.5% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
167. Timolol Maleate Composition:

 

&Polyvinyl Alcohol Eye Drops Timolol Maleate Eq. to Timolol IP 0.5% w/v
Polyvinyl Alcohol IP 1.4% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
168. Tropicamide Eye drops IP Composition:
Tropicamide IP 1% w/v
Benzalkonium Chloride solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
169. Tropicamide with Phenylephrine Hydrochloride Eye Drops Composition:
Tropicamide IP 0.8%&1.0% w/v
Phenylephrine Hydrochloride IP 5% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v
Sterile Aqueous Base Q.S
170. Tobramycin Ophthalmic Ointment USP Each gm contains:
Tobramycin Sulphate Eq. to Tobramycin IP 0. 3% w/w
Benzalkonium chloride solution (As Preservative) IP 0.01%&0.02% v/w
Sterilized Paraffin Base q.s.
171. Tobramycin Sulphate & HPMC Ophthalmic Solution Composition :
Tobramycin Sulphate

Eq. to Tobramycin

 IP 0.3% w/v
Hydroxypropylmethylcellul ose IP 0.025% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s
172. Tobramycin Sulphate and

Dexamethasone Sodium Phosphate Ophthalmic Solution

 Composition :
Tobramycin Sulphate Eq. to Tobramycin IP 0.3% w/v
Dexamethasone Sodium Phosphate

Eq.to Dexamethasone phosphate

 IP  

 

0.1%

  

 

w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
173. Tobramycin Sulfate & Dexamethasone Sodium Phosphate & HPMC Ophthalmic Solution Composition :
Tobramycin Sulphate Eq. to Tobramycin IP 0.3% w/v
Dexamethasone Sodium Phosphate IP 0.1% w/v
Hydroxypropylmethyl cellulose IP 0.025% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02% v/v

 

Sterile Aqueous Base q.s
174. Tobramycin, Betamethasone &HPMC Ophthalmic Solution Composition:
Tobramycin Sulphate Eq. to Tobramycin IP 0.3% w/v
Betamethasone Sodium Phosphate IP 0.1% w/v
Hydroxypropylmethyl Cellulose IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Aqueous Base q.s
175. Tobramycin &Fluorometholone Ophthalmic Suspension Composition:
Tobramycin Sulphate Eq. to Tobramycin IP 0.3% w/v
Fluorometholone IP 0.1% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Suspension Base q.s
176. Tobramycin

,Fluorometholone& HPMC Ophthalmic Suspension

 Composition:
Tobramycin Sulphate Eq. to Tobramycin IP 0.3% w/v
Fluorometholone IP 0.1% w/v
Hydroxypropylmethyl

cellulose

 IP 0.025% w/v
Benzalkonium Chloride Solution(As Preservative) IP 0.02% v/v
Sterile Suspension Base q.s
177. Tetrahydrozoline HCL

Ophthalmic Solution USP

 Composition:
Tetrahydrozoline

Hydrochloride

 USP 0.05% w/v
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02% v/v
Sterile Aqueous Base q.s.
178. Travoprost Ophthalmic Solution IP Composition:
Travoprost IP 40 mcg
Benzalkonium Chloride Solution

(As Preservative)

 IP 0.02 % v/v
Sterile suspension Base q.s.
179. Travoprost& Timolol Maleate

Ophthalmic Solution IP

 Composition:
Travoprost IP 0.004% w/v
Timolol Maleate Eq. to Timolol IP 0.5% w/v
Benzalkonium Chloride Solution (As Preservative) IP 0.02 % v/v
Sterile suspension Base q.s.

For enquiries related to COPP , Manufacturing , Third-Party Manufacturing,PCD Pharma Franchise, and Pharmaceutical, Nutraceutical & Ayurvedic Products, our dedicated team is ready to assist you.

Whether you are looking for product quotations, business partnerships, third-party manufacturing opportunities, or product-related support, please feel free to get in touch with us.

Phone: +91 82647 25769
WhatsApp: +91 82647 25769
Email: [email protected]
Website: https://aasplifesciences.com/

We look forward to connecting with you, understanding your requirements, and building a long-term business partnership. Let us work together to create new opportunities and support your business growth.

AASP Lifesciences Pvt. Ltd. — Your Trusted Partner in Pharmaceutical & Healthcare Solutions.

Post Views: 11